Gene · 10460
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Small Molecule Ligand Binding Sites On and In the ARNT PAS-B Domain. | bioRxiv | 2024 | 37961463 | PubTator, text mining | PubMed |
Family with sequence similarity 111 member B contributes to tumor growth and metastasis by mediating cell proliferation, invasion, and EMT via transforming acidic coiled-coil protein 3/PI3K/AKT signaling pathway in hepatocellular carcinoma. | Environ Toxicol | 2024 | 37782700 | PubTator, text mining | PubMed |
| RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities. | Genes Dis | 2024 | 37692504 | PubTator, text mining | PubMed |
| A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors. | Oncologist | 2024 | 37619245 | PubTator, text mining | PubMed |
| Coordinating single-cell and bulk RNA-seq in deciphering the intratumoral immune landscape and prognostic stratification of prostate cancer patients. | Environ Toxicol | 2024 | 37565774 | PubTator, text mining | PubMed |
| A diffuse glioma with oligodendroglial-like cells and extensive calcifications. | Brain Pathol | 2024 | 37409721 | PubTator, text mining | PubMed |
| Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer. | Front Oncol | 2023 | 38282676 | PubTator, text mining | PubMed |
| TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. | Cell Cycle | 2023 | 38197196 | PubTator, text mining | PubMed |
| Applications and advancements of CRISPR-Cas in the treatment of lung cancer. | Front Cell Dev Biol | 2023 | 38188023 | PubTator, text mining | PubMed |
| Druggable genomic landscapes of high-grade gliomas. | Front Med (Lausanne) | 2023 | 38143440 | PubTator, text mining | PubMed |
| Endosulfine alpha maintains spindle pole integrity by recruiting Aurora A during mitosis. | BMC Cancer | 2023 | 38129815 | PubTator, text mining | PubMed |
| Polymorphous low-grade neuroepithelial tumor of the young with FGFR3-TACC3 fusion mimicking high-grade glioma: case report and series of high-grade correlates. | Front Oncol | 2023 | 38074682 | PubTator, text mining | PubMed |
| Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. | Int J Mol Sci | 2023 | 38069284 | PubTator, text mining | PubMed |
| Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. | Cancers (Basel) | 2023 | 38067373 | PubTator, text mining | PubMed |
| Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives. | Cancers (Basel) | 2023 | 38067258 | PubTator, text mining | PubMed |
| Outbreak of extensively drug-resistant Serratia marcescens in an intensive care unit. | Antimicrob Steward Healthc Epidemiol | 2023 | 38028922 | PubTator, text mining | PubMed |
| Hypothalamic and Pituitary Dysfunction After Extensive Brain Surgery: There Is Thirst for More Knowledge. | JCEM Case Rep | 2023 | 38021079 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. | Cell Death Dis | 2023 | 38012214 | PubTator, text mining | PubMed |
| Discovery of Pyrazolo[1,5-a]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML. | J Med Chem | 2023 | 37983486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10460/papers?page=7